- Home
- XNCR vs SAFE Comparison
XNCR vs SAFE Comparison
Compare XNCR & SAFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | SAFE |
|---|---|---|
| Founded | 1997 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2013 | 1999 |
Fundamental Metrics
Financial Performance| Metric | XNCR | SAFE |
|---|---|---|
| Price | $19.84 | $16.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 10 |
| Target Price | ★ $22.33 | $19.00 |
| AVG Volume (30 Days) | ★ 1.0M | 274.0K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.48% |
| EPS Growth | ★ 65.36 | 7.43 |
| EPS | N/A | ★ 0.82 |
| Revenue | $125,576,000.00 | ★ $385,552,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.80 | $4.31 |
| P/E Ratio | ★ N/A | $20.01 |
| Revenue Growth | ★ 13.65 | 5.43 |
| 52 Week Low | $6.92 | $12.76 |
| 52 Week High | $21.76 | $17.45 |
Technical Indicators
Market Signals| Indicator | XNCR | SAFE |
|---|---|---|
| Relative Strength Index (RSI) | 62.00 | 48.86 |
| Support Level | $11.20 | $13.99 |
| Resistance Level | $21.26 | $16.54 |
| Average True Range (ATR) | 1.59 | 0.49 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 73.60 | 25.00 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.